Table 2:

Comparisons between patients who had favorable and unfavorable outcomes 3 months after recanalization

Patient Demographics% or Median (IQR)P
Favorable Outcome (n = 22)Unfavorable Outcome (n = 13)
Age (yr)64 (61–69)73 (65–77).040
Male90.984.6.618
Medical history
    Diabetes mellitus22.715.4.689
    Hypertension54.553.81.000
    Hypercholesterolemia27.330.81.000
    Smoking45.553.8.733
    Cardiac disease18.27.7.630
    Prior stroke9.130.8.166
Preprocedural findings
    Time to hospital (min)a180 (138–208)180 (100–210).851
    Time to IA therapy (min)a255 (200–279)280 (180–360).669
    NIHSS score at admission9 (8–14)17 (13–18).003
    Modified Rankin Scale score4 (3–4)4 (4–4).005
        345.57.7.027
        454.569.2.486
        50.023.1.044
    Right-sided occlusion27.369.2.032
Tandem occlusion site.247b
        M163.684.6.259
        M222.70.0.134
        Distal ICA thrombus13.615.41.000
    Received IV rtPA18.230.8.433
Periprocedural findings
    Procedure duration (min)90 (66–128)95 (70–110).891
    Urokinase dose (×104 U)10 (10–30)20 (10–20).648
    TICI grade.006c
        IIa9.153.8.006
        IIb22.715.4.689
        III68.230.8.043
Complications0.015.4.144
        Symptomatic hemorrhage0.07.7.371
        Brain swelling0.07.7.371
Follow-up evaluation at 3 months
    NIHSS scored2 (2–4)9 (6–16)<.001
  • Note:—IQR indicates interquartile range; IA, intra-arterial.

  • a From onset of symptoms.

  • b Fisher exact test.

  • c χ2 test for trend. Favorable outcome was defined as a modified Rankin Scale score of ≤2 at 3 months.

  • d Excluding the 4 patients who died within 3 months.